؊ channel. CFTR is increasingly recognized as a component of multiprotein complexes and although several inhibitory proteins to CFTR have been identified, protein complexes that stimulate CFTR function remain less well characterized. We report that annexin 2 (anx 2)-S100A10 forms a functional cAMP/PKA/calcineurin (CaN)-dependent complex with CFTR. Cell stimulation with forskolin/3-isobutyl-1-methylxanthine significantly increases the amount of anx 2-S100A10 that reciprocally coimmunoprecipitates with cell surface CFTR and calyculin A. Preinhibition with PKA or CaN inhibitors attenuates the interaction. Furthermore, we find that the acetylated peptide (STVHEILCKLSLEG, Ac1-14), but not the nonacetylated equivalent N1-14, corresponding to the S100A10 binding site on anx 2, disrupts the anx 2-S100A10/CFTR complex. Analysis of 4,4-diisothiocyanatostilbene-2,2-disulfonic acid (DIDS) and CFTR inh172 -sensitive currents, taken as indication of the outwardly rectifying Cl ؊ channels (ORCC) and CFTRmediated currents, respectively, showed that Ac1-14, but not N1-14, inhibits both the cAMP/PKA-dependent ORCC and CFTR activities. CaN inhibitors (cypermethrin, cyclosporin A) discriminated between ORCC/CFTR by inhibiting the CFTR inh172 -, but not the DIDS-sensitive currents, by >70%. Furthermore, peptide Ac1-14 inhibited acetylcholine-induced short-circuit current measured across a sheet of intact intestinal biopsy. Our data suggests that the anx 2-S100A10/CFTR complex is important for CFTR function across epithelia.
INTRODUCTION

Cystic fibrosis (CF) is caused by a mutated Cl
Ϫ channel, the cystic fibrosis transmembrane conductance regulator (CFTR), and manifests as a series of disorders that affect the respiratory, digestive, and reproductive systems. Mature wild-type CFTR resides in the apical membrane where it controls ion and fluid transport. A fraction of CFTR is detectable in association with membranes of the secretory pathway (Bradbury, 1999) . The majority of CF patients carry the F508del-CFTR mutation, which causes improper folding of the CFTR protein affecting its traffic through the secretory pathway (Kerem et al., 1989; Bertrand and Frizzell, 2003) .
Although there is no significant difference between wildtype and CF cells with regard to forskolin (FSK)-stimulated adenylyl cyclase activity (Mak et al., 2002) , CF airway and gut epithelia are nevertheless characterized by a failure to generate Cl Ϫ flux after stimulation with cAMP agonists. In addition, Bradbury et al. (1992) found that mutant CF epithelia exhibited no cAMP-dependent regulation of endocytosis or exocytosis until they were transfected with cDNA encoding wild-type CFTR. Furthermore, Bebok et al. (2005) failed to restore cAMP-dependent Cl Ϫ flux in F508del-CFTR CFBE41o
Ϫ cells grown at 27°C to allow "rescue" of F508del-CFTR by promoting its maturation to the apical membrane. These data suggest the existence of a signaling defect downstream of cAMP generation in CF cells. However, signal transduction pathways and resulting protein complexes that regulate CFTR function at the apical membrane are unknown. For example, although phosphorylation by cAMPdependent protein kinase A (PKA) is the major intracellular signaling mechanism for activation of CFTR, the precise means by which PKA phosphorylation of CFTR induces Cl plasma membrane in various cell types, and at the same time it activates other cellular processes that may or may not be related to CFTR function (Nakamura and Gold, 1987; DiFrancesco and Tortora, 1991; Bos et al., 2003) . In some polarized epithelial cells, CFTR is internalized rapidly from the plasma membrane solely through the clathrin-mediated pathway indicating that endocytosis may influence the residence time of CFTR at the cell surface. It has also been suggested that cAMP-stimulated CFTR may regulate plasma membrane recycling. It is clear that CFTR mutation disrupts intracellular trafficking of CFTR (Bradbury, 1999; Weixel and Bradbury, 2000) , and although controversial, increasing evidence indicates that in some cell types, F508del-CFTR is potentially functional and present at the plasma membrane (Kalin et al., 1999; Penque et al., 2000) . Furthermore, recent work showed that CFTR is efficiently processed to post-Golgi compartments (Varga et al., 2004) and defective intracellular trafficking, endocytosis and exocytosis observed in CF strongly suggest that CFTR may interact with and regulate proteins of the secretory pathway.
Annexins bind negatively charged phospholipids and cellular membranes in a calcium-dependent manner (Moss, 1992; Rety et al., 1999; Gerke and Moss, 2002; SantamariaKisiel et al., 2006) , share significant sequence homology with CFTR around the region of the most common CF mutation (Chap et al., 1991) , and are also implicated in the regulation of vesicular traffic (Creutz, 1992) . They are frequently associated with membrane compartments engaged in endocytosis and exocytosis (Turpin et al., 1998; Gerke and Moss, 2002; Zobiack et al., 2003) . In addition, annexins interact with cytoskeletal proteins, to modulate formation of membrane vesicles and membrane fusion.
Annexin 2 (anx 2) forms a heterotetrameric complex with S100A10 (Santamaria-Kisiel et al., 2006) . S100A10 (previously known as p11, calpactin I light chain, and annexin II ligand) is a dimer composed of two 11-kDa subunits, which belongs to the S100 calcium binding protein superfamily, and it functions as one of the mediators of calcium-dependent signaling pathway. Anx 2-S100A10 complex, located at the inner surface of the plasma membrane, is found associated with clathrin-coated vesicles and early endosomes (Emans et al., 1993; Turpin et al., 1998) , and it regulates vesicle routing from the trans-Golgi network to the apical membrane (Jacob et al., 2004) . Thus, anx 2 is involved in membrane fusion, trafficking, and regulating the interaction among ion channels, S100A10, and the cytoskeleton (Ali et al., 1989; Gerke and Moss, 2002) . In this regard, both anx 2 and S100A10 interact with and regulate the translocation and function of Na ϩ , K ϩ , and Ca 2ϩ channels (Girard et al., 2002; Okuse et al., 2002; van de Graaf et al., 2003) .
Association between several annexins and specific S100 proteins is calcium dependent (Santamaria-Kisiel et al., 2006) . However, the anx 2-S100A10 interaction is uniquely calcium independent (Rety et al., 1999; Gerke and Moss, 2002; Santamaria-Kisiel et al., 2006) . We recently found that cAMP/PKA regulates the anx 2-S100A10 complex in epithelia (Muimo, 2006) . Given that anx 2-S100A10 complex is cAMP/PKA dependent and that CFTR is also regulated by cAMP/PKA (Naren et al., 1999; Dahan et al., 2001) , we speculated that anx 2-S100A10 complex may be important for CFTR function.
In this study, we report the formation of a cAMP/PKAdependent complex between anx 2, S100A10, and CFTR in epithelia, which is important for CFTR function. We report that cAMP/PKA, in a pathway involving calcineurin (CaN, protein phosphatase [PP]2B), induces formation of the anx 2-S100A10/CFTR complex, leading to an increase in CFTRmediated currents. Accordingly, CFTR function is inhibited when the anx 2-S100A10 complex is disrupted by pretreatment of the cells with CaN inhibitors or a specific peptide corresponding to the anx 2 binding site on S100A10 before FSK stimulation. This study identifies and provides insight into a dynamic cAMP/PKA-dependent CFTR-associated macromolecular complex that may play an important role in regulating CFTR activity in epithelia.
MATERIALS AND METHODS
Cell Culture
Cells, human bronchial epithelial cell line (16HBE14o Ϫ ) (Gruenert et al., 2004) , were cultured in medium 199 plus fetal calf serum as described previously (Cozens et al., 1994) until confluent. Membrane and cytosolic fractions were prepared as described previously (Muimo et al., 2000) .
Human Nasal Epithelium (HNE)
HNE were obtained as described previously from healthy young adults undergoing surgery for reasons unrelated to nasal mucosal disease (Mwimbi et al., 2003) . Local ethical committee approval and written informed consent were obtained. Nasal brushings were suspended in complete medium 199 until use or storage in liquid nitrogen.
Gut Biopsy
With local ethical committee approval and written informed consent, a sheet of stripped intestine was obtained endoscopically from the distal ileum and the potential difference (PD), short-circuit current (SCC), and tissue resistance were measured using a modified Ussing chamber technique as described previously (Hardcastle et al., 2001) . Briefly, the sample was mounted in an Ussing chamber with an aperture of 0.03 cm 2 and incubated at 37°C in Krebs bicarbonate saline gassed with 95% O 2 , 5% CO 2 . The serosal fluid contained 10 mM glucose and the mucosal fluid 10 mM mannitol. Tissue resistance was determined from the PD change induced by a 50-A current pulse. SCC was calculated from PD and resistance measurements using Ohm's law. After 10-min stabilization, readings of electrical activity were taken at 1-min intervals. Acetylcholine (Ach; 10 Ϫ3 M) was added to the serosal solution after 5 min of basal readings, and measurements were taken for a further 5 min before washout of Ach. Glucose (10 mM) was then added mucosally to confirm tissue viability. After removal of glucose, the tissue was allowed to recover for 10 min, and then N1-14 was added to mucosal and serosal solutions, and tissue incubated for 30 min. Readings were repeated for Ach and glucose as described above. After washout of N1-14 and glucose (10 min), the procedure was repeated for Ac1-14.
Immunoprecipitation, Immunoblotting, and Overlay or Far Western Assays
Immunoprecipitation and immunoblotting procedures were conducted essentially as described previously (Muimo et al., 2000) . For overlay analysis, proteins were extracted from postnuclear membranes of airway epithelia with Triton X-100. Extracted proteins, CFTR, or anx 2 immunoprecipitate, separated by SDS-polyacrylamide gel electrophoresis (PAGE) were blotted onto polyvinylidene difluoride (PVDF). Blot was blocked with 1ϫ Tris-buffered saline containing 5% nonfat dry milk Ϯ extract (500 g of protein) and incubated at room temperature for 60 min. Blot was washed (4 times) and then probed with anti-anx 2 (1:2000) and anti-S100A10 (1:1000).
Laser Confocal Microscopy
HNE suspended in complete medium 199 were treated with either FSK/3-isobutyl-1-methylxanthine (IBMX) for 30 min or protein kinase inhibitor (PKI) for 5 min before the addition of FSK/IBMX for a further 30 min. Control cells were incubated in complete medium 199 alone. HNE were fixed in 4% paraformaldehyde for 30 min at RT, quenched with 100 mM glycine, permeabilized (1% Triton X-100, 1X phosphate-buffered saline [PBS]) for 30 min at room temperature (RT), washed (3 times), and blocked with 1% bovine serum albumin (BSA) for 60 min at RT. Cells were incubated overnight at 4°C with anti-anx 2 goat (1:100), anti-S100A10 mouse (1:100) in PBS for 60 min, washed (3 times), and then incubated with with anti-mouse fluorescein isothiocyanate and anti-goat rhodamine (1:100) for 60 min RT. Cells were washed five times with 1X PBS and resuspended in 70% glycerol. Slides were examined by laser confocal microscopy (LSM-510; Carl Zeiss, Jena, Germany). Images were acquired and analyzed using Zeiss software. and then biotinylated using 1 mg/ml EZ-Link sulfosuccinimidyl 2-(biotinamido)-ethyl-1,3-dithiopropionate for 30 min at 4°C. Free biotin was washed three times with ice-cold 1X PBS containing 0.1% BSA and then with ice-cold 1X PBS. Cells were then scraped in ice-cold homogenization buffer (Muimo et al., 2000) and sonicated. Cell lysate was centrifuged at 300 ϫ g for 2 min, and the pellet was discarded. Prewashed avidin agarose beads in PBS were added to the supernatant and incubated for 30 min at RT. Avidin-bound complexes were pelleted (350 ϫ g) for 2 min and washed five times. Biotinylated proteins were eluted in Laemmli buffer, resolved by SDS-PAGE, electrotransferred, and immunoblotted with the CFTR, anx 2, and S100A10 antibody.
Whole Cell Recordings
16HBE14o
Ϫ grown on plastic coverslips were placed in a perspex bath on the stage of an inverted microscope (Olympus IX70; Olympus, Tokyo, Japan). Standard patch-clamp experiments were used to investigate whole-cell currents (Hamill et al., 1981) . Voltage protocols were controlled by an IBMcompatible computer, equipped with a Digidata interface (Axon Instruments, Foster City, CA) and pClamp software, Clampex 8.0 (Axon Instruments). A List EPC-7 amplifier was used to make recordings.
Whole cell recordings were obtained at room temperature with Na ϩ Ringer in the bath, containing 140 mM NaCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 40 mM mannitol, and 10 mM HEPES (titrated to pH 7.4 with NaOH). The pipette contained 135 mM CsCl, 2 mM EGTA, 2 mM MgCl 2 , 2 mM Na 2 ATP, and 10 mM HEPES (titrated to pH 7.4 with CsOH). Whole cell currents were saved onto the hard disk of the computer after low-pass filtering (5 kHz). Cell potential was clamped to Ϫ40 mV, and then it was stepped to betweenϩ100 and Ϫ100 mV, in Ϫ20 mV steps. Average currents were derived using Excel 2000 (Microsoft, Redmond, WA). Cell area was calculated from capacity transients seen in response to a 20-mV potential step, with membrane capacitance assumed to be 1 F/cm 2 . The mean capacitance of cells was 23.2 Ϯ 1.30 pF (n ϭ 57). Previous studies have indicated that 16HBE14o Ϫ contain both CFTR and 4,4Ј-diisothiocyanatostilbene-2,2Ј-disulfonic acid (DIDS)-sensitive Cl Ϫ conductances (Schwiebert et al., 1994) . Therefore, 500 M DIDS was added to the bath to provide the magnitude of the DIDS-sensitive conductance. The magnitude of the CFTR currents was determined by the further addition of 10 M CFTR inh172 to the bath (in the continued presence of DIDS) (Ma et al., 2002) .
To activate cAMP/PKA, cells were incubated with FSK/IBMX for 30 min. To examine the effect of CaN inhibitors on CFTR function, cells were incubated for 5 min in the presence of either 5 nM cypermethrin or 1 M cyclosporin A, before incubation for 30 min in the presence of the inhibitor plus FSK/IBMX. When the effect of Ac1-14 and N1-14 was tested, cells were incubated in the presence of the peptides (0.16 mg/ml for each) for 30 min before an additional 30 min in the presence of the peptides plus FSK/IBMX. For all experiments, a separate control data set was obtained in the absence of inhibitor or peptide on the same day.
Solutions, Chemicals, Reagents, and Antibodies Used in This Study
Osmolality of the experimental solutions was checked using a Roebling osmometer and adjusted to 300 Ϯ 1 mOsm⅐kg Ϫ1 H 2 O by using mannitol or water as appropriate. All chemicals unless otherwise indicated were purchased from Sigma-Aldrich (Poole, Dorset, United Kingdom). PVDF membranes were from Millipore (Watford, United Kingdom), and acrylamide and other electrophoretic reagents were from Bio-Rad (Hemel Hempsted, United Kingdom). Calyculin A, okadaic acid, cypermethrin, ethyl]-5-isoquinolinesulfonamide (H-89), and myristoylated protein kinase A inhibitor amide 14-22 were from Calbiochem (Nottingham, United Kingdom). Peptides (Ͼ95% purity) were from Sigma Genosys (Haverhill, Suffolk, United Kingdom). Fetal calf serum was from Invitrogen (Paisley, UK). Antiphosphoserine and anti-phosphothreonine monoclonal antibodies (Q5 and Q7, dilution 1:500; QIAGEN, Dorking, Surrey, United Kingdom), anti-phosphotyrosine (PY99, 1:5000; Autogen Bioclear, Wiltshire, United Kingdom), anti-CaN (1:1000; Sigma-Aldrich), anti-CFTR monoclonal (Lab Vision Products, Cheshire, United Kingdom), and polyclonal (1:1000, R&D Systems Europe, Abingdon, Oxfordshire, United Kingdom), anti-S100A10 (H21; 1:4000), anti-anx 2 monoclonal (HH7, 1:7000), polyclonal (goat 1:2000; all Autogen Bioclear) have been described previously (Thiel et al., 1992) .
Data Analysis
Results are presented as mean Ϯ SEM. Effects of experimental interventions were assessed by Student's t test (or analysis of variance [ANOVA] ) and significance was assumed at the 5% level. Unless otherwise indicated all immunoblots are representative of at least three independent experiments.
RESULTS
Anx 2-S100A10 Forms a cAMP/PKA-dependent Complex with CFTR
Because the anx 2-S100A10 complex regulates a number of ion channels (Girard et al., 2002; Okuse et al., 2002; van de Graaf et al., 2003) and cAMP/PKA regulates CFTR Cl Ϫ flux (Naren et al., 1999; Dahan et al., 2001) , we predicted that anx 2-S100A10 may form a cAMP/PKA-dependent complex with CFTR. Immunoblot analysis of CFTR immunoprecipitates for anx 2 and S100A10 showed that both proteins coprecipitated with CFTR ( Figure 1A ). However, when the immortalized human bronchial epithelial cells (16HBE14o Ϫ ) ( Figure 1A ) and HNE cells ( Figure 1B) were stimulated with 10 M FSK/100 M IBMX, increased amounts of anx 2 and S100A10 coimmunoprecipitated with CFTR. Pretreatment of the cells with 100 mM PKI (myristoylated PKA inhibitor amide 14-22; Cheng et al., 1986) before FSK/IBMX stimulation reduced the level of anx 2 and S100A10 that coimmunoprecipitated with CFTR ( Figure 1, A and B) . Additionally, the reverse experiment also showed that FSK/IBMX stimulation increased the level of CFTR precipitating with anx 2 (Figure 1, C and D) , and inhibition of PKA using PKI attenuated the amount of CFTR that coimmunoprecipitated with anx 2-S100A10. Figure 1E shows that when a blot containing membrane proteins (100 g) from 16HBE14o
Ϫ is overlaid with solubilized membrane proteins (0.5 mg/ml), anx 2 staining is additionally observed at 175 kDa (expected size for CFTR) in the presence of 100 M dioctanoyl-cAMP. Thus, cAMP/PKA may regulate the anx 2-S100A10/CFTR interaction in bronchial and airway epithelia.
The acetylated synthetic peptide comprising the N-terminal 14 amino acids of anx 2 [Acetyl-STVHEILCKLSLEG (Ac1-14)] specifically disrupts anx 2 binding to S100A10 (Becker et al., 1990; Kube et al., 1992; Nilius et al., 1996; Konig et al., 1998) . In contrast, the nonmodified peptide STVHEILCKLSLEG (N1-14) (Nilius et al., 1996; Konig et al., 1998) , fails to disrupt the anx 2-S100A10 complex. To analyze the ability of Ac1-14 to disrupt the anx 2-S100A10/CFTR complex, immunoprecipitates were incubated with 100 M peptide for 30 min at 30°C and then centrifuged. Ac1-14 ( Figure 1F , lanes 3 and 4), but not N1-14 ( Figure 1F , lanes 5 and 6), released anx 2 into supernatant, whereas S100A10 remained bound to the CFTR immunoprecipitate. In the reverse experiment, Ac1-14 ( Figure 1G , lanes 3 and 4), but not N1-14 ( Figure 1G , lanes 5 and 6) released CFTR from the anx 2 immunoprecipitate. This suggested that Ac1-14 can disrupt preformed cAMP/PKA-dependent anx 2-S100A10/CFTR complex and that association of anx 2 with CFTR requires the presence of S100A10. In the reverse experiment, release of CFTR (alongside S100A10) from the anx 2 immunoprecipitate provided further supportive evidence for the potential role of S100A10 as a bridging molecule between CFTR and anx 2.
Immunolocalization of anx 2 and S100A10 in HNE treated with or without FSK and/or PKA inhibitors was used to examine the impact of cAMP and PKA on cellular distribution of these proteins. In unstimulated HNE, S100A10 staining was observed predominantly at or near the plasma membrane/cell junction, whereas anx 2, although predominately located at the plasma membrane, was also distributed throughout the cell, including the nucleus, Figure 2A . Colocalization of S100A10 and anx 2 was limited to the plasma membrane/cell junctions. After cell stimulation with FSK/IBMX, a reduction in anx 2 nuclear staining was observed combined with an enhanced staining of the protein both intracellularly and at the plasma membrane/cell junction ( Figure 2B ). FSK/IBMX stimulation resulted in a more even distribution of S100A10 throughout the cell except the nuclei. Therefore, enhanced colocalization of anx 2 and S100A10 was observed throughout the cell, including the plasma membrane, but not the nuclei of stimulated cells. Additionally, inhibition of PKA activity using PKI or the inhibitory Rp-cAMP analogue (100 M) before FSK/IBMX stimulation resulted in enhanced anx 2 nuclear staining and a reduced colocalization between anx 2 and S100A10 within the cytoplasm and plasma membrane (Figure 2, C and D) . PKI alone also generated enhanced nuclear localization of anx 2, confirmed by Western blot analysis of fractionated cells (not shown). These data suggested that cAMP/PKA might regulate the interaction, distribution, and function of anx 2 and S100A10 in airway epithelia.
Anx 2-S100A10 Complex Binds Cell Surface CFTR
We speculated that the cAMP/PKA-induced anx 2-S100A10 complex might associate with cell surface CFTR and regulate CFTR function. After cell surface biotinylation, the membrane fraction was depleted of biotin-labeled (cell surface/ integral membrane) proteins by avidin agarose precipitation. Figure 3A shows the presence of CFTR in all avidin precipitates, with no detectable change in the amount of cell surface CFTR in FSK stimulated cells. In contrast, anx 2 and S100A10 staining increased in the avidin precipitate after FSK stimulation ( Figure 3A , lane 2) and preinhibition of PKA attenuated the increase ( Figure 3A, lane 3) . To assess whether anx 2-S100A10 also associates with noncell surface CFTR, CFTR immunoprecipitates from cell extracts (ϮFSK/ IBMX stimulation) depleted of cell surface/integral membrane proteins, by avidin precipitation, were probed for anx 2 and S100A10. Figure 3 , B and C, show that, despite the presence of all three proteins, anx 2 and S100A10 did not coimmunoprecipitate with CFTR from these fractions. Similarly, in the reverse experiment, CFTR staining is undetectable in anx 2 immunoprecipitates from fractions depleted of biotin-labeled proteins. Conversely, it is worth noting that the FSK-dependent interaction between anx 2 and S100A10 occurred in fractions depleted of biotin-labeled proteins ( Figure 3C ). Thus, after cAMP/PKA stimulation, there was increased coprecipitation of anx 2 and S100A10 with cell surface CFTR, but not noncell surface CFTR, suggesting that the cAMP/PKA-induced anx 2-S100A10 complex tethers to cell surface CFTR.
CaN Mediates the cAMP/PKA-dependent Anx 2-S100A10/ CFTR Interaction
Because CaN is important for the cAMP/PKA-dependent anx 2-S100A10 complex formation (Muimo, 2006) , we hypothesized that CaN may also be relevant to the cAMP/PKA-induced anx 2-S100A10 interaction with CFTR. We analyzed the composition of the complex in membranes of 16HBE14o Ϫ pretreated with phosphatase inhibitors (100 nM calyculin A, 5 nM cypermethrin, or 1 m okadaic acid) before FSK/IBMX treatment. We found that, alongside anx 2-S100A10 complex formation, the FSK-induced anx 2-S100A10/CFTR complex Ϫ membrane proteins (100 g) probed for anx 2. Lanes: control (1), blot overlaid with 0.5 mg/ml solubilized membrane proteins (2), and blot overlaid with solution 2 containing dioctanoyl cAMP (3). Results are representative of four separate experiments. (F) Ac1-14 dissociates anx 2, but not S100A10, from CFTR immunoprecipitate. Immunoblots of CFTR immunoprecipitates from 16HBE14o Ϫ lysates treated with FSK/IBMX and probed for S100A10 and anx 2 show Ac1-14 (lanes 3 and 4), but not N1-14 (lanes 5 and 6), released anx 2 from CFTR immunoprecipitate. (G) Ac1-14 dissociates CFTR from anx 2 immunoprecipitate. Immunoblots of anx 2 immunoprecipitate from 16HBE14o Ϫ cells treated with FSK/IBMX and probed for CFTR and anx 2. Ac1-14 (lanes 3 and 4), but not N1-14 (lanes 5 and 6), released CFTR from anx 2 immunoprecipitate. To confirm equal loading, blots were stripped and reprobed with anti-CFTR (R&D Systems Europe) (A, B, and F) or anti-anx 2 (HH7) (C, D, and G). was time dependent (Figure 4, A and B, lanes 1-3) . Importantly, cypermethrin, a CaN phosphatase selective inhibitor that does not inhibit PP1, PP2A, or other PPs (Liu et al., 1991; Sistiaga and Sanchez-Prieto, 2000) , disrupted complex formation and reduced CFTR coimmunoprecipitation with anx 2 ( Figure 4A, lane 5) . Conversely, okadaic acid or calyculin A, at concentrations well above the reported IC 50 values for PP1 and PP2A (MacKintosh and MacKintosh, 1994; Herzig and Neumann, 2000) , showed little or no inhibitory effect on the cAMP/PKA-dependent complex (Figure 4, A and B) . Additionally, preincubation of the cells with 1 M cyclosporin A, an established potent and selective inhibitor for CaN (Liu et al., 1991; Yakel, 1997) inhibited the FSK-induced complex ( Figure 4B, lane 4) . Analysis of S100A10 immunoprecipitates from membranes of 16HBE14o Ϫ pretreated with cyclosporin A and cypermethrin before FSK stimulation showed that both CaN inhibitors inhibit interaction between S100A10, annexin 2, and CFTR ( Figure 4C) .
Disruption of the cAMP/PKA-induced complex by CaN inhibitors suggested that CaN might be part of the cAMP/ PKA-dependent anx 2/S100A10/CFTR macromolecular complex ( Figure 4C ). 4D). Similar results were obtained in the reverse experiment, when CaN immunoprecipitates from similar cell preparations were probed for anx 2 ( Figure 4E ). Thus, CaN may form part of the cAMP/PKA-dependent anx 2-S100A10/ CFTR complex.
Anx 2-S100A10 Complex Regulates CFTR Function
The data mentioned above suggested that anx 2-S100A10 might regulate CFTR function. The functional significance of the complex to CFTR was determined by analyzing both CFTR-mediated short-circuit current (SSC) in intact primary tissue and whole cell currents in 16HBE14o Ϫ . Whole cell currents were recorded from 16HBE14o Ϫ grown on plastic coverslips. Cells demonstrated large anionselective currents that were slightly outwardly rectifying after incubation with FSK and IBMX; Figure 5A . The current at ϩ100 mV was 118.7 Ϯ 35.59 pA/pF, whereas the current at Ϫ100 mV was Ϫ84.6 Ϯ 24.2 pA/pF (n ϭ 16). DIDS at 500 M decreased whole cell currents (see Supplemental Material) (n ϭ 16). This DIDS sensitive current was outwardly rectifying. The remaining current was sensitive to 10 M CFTR inh172 (see Supplemental Material) (n ϭ 16). This CFTR ihn172 sensitive current was ohmic. Currents sensitive to DIDS and CFTR inh172 were taken as the DIDS-sensitive current (IDIDS) and CFTR mediated current (ICFTR), respectively.
To establish the relevance of the PKA/CaN-mediated dephosphorylation of anx 2 to CFTR function, we analyzed the effect of the CaN inhibitors cypermethrin and cyclosporin A on CFTR-mediated currents. These inhibitors both reduced the magnitude of ICFTR ( Figure 5B ), but they had no effect on IDIDS (see Supplemental Material).
To distinguish between the effect of PKA-mediated CFTR phosphorylation and PKA/CaN-mediated dephosphorylation of anx 2 on CFTR function, we analyzed the impact of Ac1-14, which specifically disrupts anx 2-S100A10 complex, on ICFTR. Ac1-14 inhibited both IDIDS and ICFTR ( Figure  5C ) (n ϭ 13 and n ϭ 9 in the absence and presence of Ac1-14, respectively). However, N1-14 had no effect ( Figure 5D ). This suggests that PKA/CaN-mediated dephosphorylation of anx 2, is important for CFTR function.
For the SSC measurements, Cl Ϫ secretion in response to the intestinal secretagogue Ach (10 Ϫ3 M) Ϯ Ac1-14 or N1-14, was measured in gut biopsies mounted in modified Ussing chambers (Hardcastle et al., 2001 ) (n ϭ 3). Ach induced a transient increase in SCC in the control measurements (⌬SCC; ϩ136 Ϯ 7.63 A/cm 2 ). N1-14 was without effect on the Ach-induced increase in SCC (⌬SCC; ϩ129 Ϯ 7.03 A/ cm 2 ). However, in the presence of Ac1-14, Ach induced an attenuated increase in SCC (⌬SCC; ϩ20.0 Ϯ 3.01 A/cm 2 ). Washing out Ac1-14 did not restore the Ach response, indicating possible diffusion of peptide into the tissue. Tissue viability pre/posttreatment was confirmed using sodium linked glucose (10 mM) absorption (peak response ϩ235 Ϯ 6.9 A/cm 2 and ϩ213 Ϯ 9.9 A/cm 2 , respectively) ( Figure  5E ).
DISCUSSION
This study describes a multiprotein complex concomitantly associated with the PKA-dependent activation of CFTR. We provide evidence that a macromolecular complex associated with CFTR function assembles at the plasma membrane of epithelia upon cell stimulation with FSK or Ach. We also show that a protein phosphatase regulates the PKA-dependent activation of CFTR function. We propose that the anx 2-S100A10 cAMP/PKA-dependent complex associates with CFTR through a PKA signaling pathway involving CaN. Disruption of the cAMP/PKA-dependent complex, by pharmacological inhibitors of CaN or by Ac1-14, attenuates CFTR function.
Stimulation of normal epithelia with FSK generates Cl Ϫ flux through CFTR phosphorylation by PKA (Gadsby and Nairn, 1999) . This pathway is the major recognized intracellular signaling mechanism for activation of CFTR-dependent Cl Ϫ flux. Our data demonstrate that CFTR activation by PKA is dependent on CaN and anx 2-S100A10 complex formation; preincubation of the cells with either CaN inhibitors or Ac1-14, which disrupts anx 2-S100A10 complex, before FSK stimulation inhibits both anx 2-S100A10/CFTR complex formation and CFTR Cl Ϫ conductance. Importantly, our data have a wider relevance to epithelial function because inhibition of the Ach-dependent SCC by Ac1-14 in Ϫ lysates Ϯ FSK or PKI/FSK/IBMX, biotinylated for 30 min at 4°C and probed for CFTR, anx 2, and S100A10. Cell surface CFTR associates with anx 2 and S100A10. (B) Immunoblots of anx 2 immunoprecipitates from 16HBE14o Ϫ lysates Ϯ FSK or PKI/FSK/IBMX (postavidin precipitation in A) probed for CFTR, S100A10, and anx 2. Anx 2 does not associate with noncell surface CFTR. (C) Immunoblots of CFTR immunoprecipitates from 16HBE14o Ϫ lysates Ϯ FSK or PKI/FSK/IBMX (postavidin precipitation in A) probed for CFTR, S100A10, and anx 2. Noncell surface CFTR does not associate with S100A10 and anx 2. To confirm equal loading of the immunoprecipitates, blots were stripped and reprobed with anti-anx 2 (HH7; B) or anti-CFTR (R&D Systems Europe; C). human gut biopsies suggests that the macromolecular complex is likely to be important in vivo in epithelia affected by cystic fibrosis. Thus, these observations highlight the fact that regulation of CFTR by cAMP/PKA in vivo is a complex process and may have implications for conclusions drawn from studies conducted in vitro and in heterologous systems.
CaN is a serine/threonine protein phosphatase regulated by [Ca 2ϩ ] i and calmodulin (Crabtree, 1999) . The disruption or stimulation of anx 2/CaN coimmunoprecipitation by PKA inhibition or activation, respectively, indicates that cAMP/ PKA regulates physical association of CaN with the anx 2/S100A10/CFTR complex. The mechanism involved is unclear, but it is likely to involve protein phosphorylation, because catalytic inhibitors of PKA disrupt coimmunoprecipitation. CFTR phosphorylation by PKA may induce a structural modification of CFTR and facilitate anx 2-S100A10 binding; meanwhile, our unpublished data show that PKA also concurrently induces CaN-dependent loss of phosphate from anx 2, which is important for complex formation with S100A10 (Muimo, 2006) . Because CaN does not dephosphorylate CFTR (Zhu et al., 1999; Thelin et al., 2005) , our application of Ac1-14 provides a novel means to distinguish between effect of inhibitors on PKA-mediated CFTR phosphorylation and PKA/CaN-mediated dephosphorylation of anx 2 on CFTR function. Inhibition of CFTR function by CaN inhibitors, despite PKA activation, suggests CaN plays an important role in the regulation of CFTR function. Interestingly, CaN A regulates PKA by dephosphorylating the PKA II regulatory subunit (Blumenthal et al., 1986; Klee et al., 1998) . Previous analyses of protein phosphatase and CFTR function have focused on CFTR dephosphorylation and inactivation by phosphatases (Zhu et al., 1999; Thelin et al., 2005) . Both PP2A and PP2C dephosphorylate and inactivate CFTR (Berger et al., 1993; Travis et al., 1997 ). In contrast, CaN and PP1 failed to inactivate and dephosphorylate CFTR after PKA phosphorylation in vitro when CaN was added directly to CFTR in excised patches. Additionally, 1 M FK506, a cell-permeant CaN inhibitor, did not alter the amount of current activated by cAMP agonists in T84 and human airway epithelia (Berger et al., 1993; Travis et al., 1997) . These studies were designed to analyze the effect of CaN on dephosphorylation and inactivation of CFTR, and they are therefore not in contradiction with our findings.
CFTR regulates other Cl Ϫ channels (Fulmer et al., 1995; Jovov et al., 1995) . The inhibition of both types of anion selective currents by Ac1-14 is in agreement with a previous study that demonstrated that disruption of the anx 2-S100A10 complex using Ac1-14 results in a gradual decrease of volume-activated Cl Ϫ currents in vascular endothelial cells (Nilius et al., 1996) . Because CFTR regulates DIDS-sensitive currents (Fulmer et al., 1995; Jovov et al., 1995) , Ac1-14 inhibition of DIDS-sensitive currents may result from CFTR inhibition. Alternatively, anx 2-S100A10 may target or regulate the DIDS-sensitive channels independently. However, these channels remain to be cloned. In contrast to Ac1-14, inhibition of CaN attenuated the CFTRmediated currents, but it was without effect on the DIDSsensitive ORCC. The reason for this difference is unclear, but it may reflect a differential regulatory role for CaN on the ORCCs. One possibility is that CaN stimulates the DIDSsensitive current through formation of the annexin-2/ S100A10 complex while simultaneously inhibiting these Cl Ϫ channels through a direct mechanism involving dephosphorylation. Overall, this would lead to inhibition of the DIDS channels, both by a loss of complex formation and by CaN-mediated inhibition. Further work will be needed to determine whether inhibition of CaN can block complex formation with concomitant loss of the inhibitory action of CaN on the DIDS-sensitive currents. The net effect is pre- dicted to alter the balance between inhibition (mediated via complex loss), versus activation (via loss of the direct action of CaN). In the current study, there was no difference in the DIDS-sensitive current with CaN inhibitors, suggesting that inhibition of CaN was sufficient to overcome the loss of complex formation. Taken, these findings suggest that the cAMP/PKA-dependent anx 2-S100A10 complex may play a significant role in the regulation of ion homeostasis in epithelia.
Anx 2-S100A10 regulates the translocation and function of various ion channels, including K ϩ , Na ϩ , and Ca 2ϩ channels (Girard et al., 2002; Okuse et al., 2002; van de Graaf et al., 2003) . It is worth noting that, in many cell types, full activation of CFTR depends on vesicular transport and subsequent fusion of vesicles containing mature CFTR with the plasma membrane (Bradbury et al., 1994; Bradbury, 1999) . This Ca 2ϩ -dependent vesicle-mediated process is triggered by cAMP/PKA and requires the C terminus of CFTR (Weber et al., 1999) . Anx 2-S100A10 regulate exocytic apical transport in polarized epithelia (Jacob et al., 2004) . Because only cell surface associated CFTR exists in complex with anx 2-S100A10, the cAMP/PKA-dependent anx 2-S100A10/ CFTR complex may tether to the plasma membrane and further work will be need to determine how this affects CFTR open probability and/or channel number in the membrane.
Several CFTR-associated proteins have been identified and some, including syntaxin and AMP-activated protein kinase (AMPK), are inhibitory to CFTR (Naren et al., 1997; Hallows et al., 2000) . Syntaxin 1A exists at the apical pole of airway epithelia and binds the N terminus of CFTR and inhibits CFTR. Reagents that disrupt the syntaxin 1A/CFTR interaction potentiate CFTR activity (Naren et al., 2000) . AMPK also binds and inhibits CFTR activity. We speculate that the binding of anx 2-S100A10 to CFTR may provide a cellular mechanism to overcome or reverse the inhibition of CFTR function induced by constitutively bound inhibitory proteins such as syntaxin 1A and AMPK.
In conclusion, our work reveals a functional interaction of annexin-2-S100A10 with CFTR that is dependent on the activity of cAMP/PKA/CaN and that complements the significant body of data showing that activation of CFTR occurs in a cAMP/PKA-dependent process. The identified interaction forms an important regulatory mechanism for CFTR function across epithelia.
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This study was supported, in part, by grants from the Cystic Fibrosis Trust and the Deutsche Forschungsgemeinschaft. The 16HBE14o Ϫ were provided by Dr. Gruenert (California Pacific Medical Center, CA). Ϫ cells stimulated with FSK/IBMX for 30 min. Whole cell currents recorded from a typical cell under the control circumstance and in the presence of 500 M DIDS and 500 M DIDS plus 10 M CFTR ihn172 . Clamp potential was stepped from Ϫ40 mV to between ϩ100 and Ϫ100 mV, in Ϫ20 mV steps. (B) Effect of CaN inhibitors cypermethrin (5 nM) and cyclosporin A (1 M) on ICFTR. Cells were incubated with CaN inhibitors for 5 min before exposure to FSK/BMX plus inhibitor for 30 min. Control currents for each data set were day matched. CaN inhibitors inhibited the cAMP/PKA-dependent CFTR, but not ORCC, activity. (C and D) Effect of Ac1-14 and N1-14 on IDIDS and ICFTR. Cells were incubated for 30 min in the presence of peptide, followed by incubation with the peptide plus FSK/IBMX for 30 min. Control currents for each data set were day matched, with control cells incubated for 30 min in control solution, followed by 30 min in the presence of FSK/IBMX. Ac1-14, but not N1-14, inhibited both the cAMP/PKA-dependent ORCC and CFTR activities. (E) Effect of Ac1-14 and N1-14 on SCC in gut epithelia. SCC measurements were obtained, in the presence or absence of Ac1-14 or N1-14 (100 M), in response to Ach and glucose stimulation of mounted gut epithelia biopsies (n ϭ 3). **p Ͻ 0.05, ANOVA.
